Related Experiment Video
Updated: May 5, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
Published on: April 25, 2016
Cortisol Testing in Septic Shock: An Evaluation of Diagnostic Performance and Predictors of Corticosteroid Use in a
Fayez Alshamsi1, Saeed Alkaabi1, Maryam Nasser Mohamedali Alfadli1
1Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
Insights
Baseline total cortisol levels showed poor accuracy in diagnosing critical illness-related corticosteroid insufficiency (CIRCI) in septic shock patients. Clinical judgment, not cortisol testing, is crucial for guiding corticosteroid therapy in this population.
Area of Science:
- Critical care medicine
- Endocrinology
- Sepsis research
Background:
- Diagnosis of critical illness-related corticosteroid insufficiency (CIRCI) is challenging due to sepsis pathophysiology.
- International guidelines now favor clinical evaluation over strict cortisol thresholds for adrenal insufficiency.
- Applicability of revised diagnostic approaches in non-Western populations is unknown.
Purpose of the Study:
- To assess the diagnostic accuracy and clinical utility of baseline total cortisol levels.
- To guide corticosteroid therapy in intensive care unit (ICU) patients with septic shock in the UAE.
- To evaluate cortisol's role in a non-Western cohort.
Main Methods:
- Retrospective observational study of ICU patients with septic shock (2012-2022).
- CIRCI defined by clinical decision to administer hydrocortisone >24 hours.
- Receiver Operating Characteristic (ROC) and Decision Curve Analysis (DCA) used.
Main Results:
- 13 of 43 patients (30.2%) received hydrocortisone; mean cortisol was higher in this group (p=0.24).
- ROC analysis showed poor diagnostic performance (AUC 0.61); guideline cutoff had 0% sensitivity.
- Clinical factors (vasopressor use, shock duration) predicted therapy; cortisol levels did not.
Conclusions:
- Baseline total cortisol has poor diagnostic accuracy and lacks clinical utility in guiding corticosteroid therapy for septic shock.
- Clinical judgment is paramount for identifying patients requiring corticosteroid therapy, aligning with international guidelines.
- Findings emphasize reliance on clinical assessment over biochemical markers in this cohort.
Abstract:
Background: Critical illness-related corticosteroid insufficiency (CIRCI) diagnosis remains controversial, largely due to the complex pathophysiology of sepsis, which challenges the reliability of conventional biochemical testing. Recent international guidelines have moved away from strict cortisol threshold-based diagnostic criteria for adrenal insufficiency, relying more on clinical evaluation. However, the applicability and diagnostic accuracy of these revised approaches in non-Western populations remain unexplored. Objective: This study aimed to assessthe diagnostic accuracy and clinical utility of baseline total cortisol levels for guiding corticosteroid therapy in a cohort of patients admitted to the intensive care unit (ICU) with septic shock in a tertiary care hospital in the United Arab Emirates. Methods: A ten-year retrospective observational study (2012-2022) of intensive care patients with septic shock was conducted. CIRCI was operationally defined by a documented clinical decision to administer hydrocortisone >24 h. Receiver Operating Characteristic (ROC) analysis assessed diagnostic performance; Decision Curve Analysis (DCA) evaluated clinical utility of performed cortisol levels. Results: Among 43 patients in the ICU with septic shock, 13 (30.2%) received hydrocortisone (CIRCI group). Mean cortisol was found to be paradoxically higher in the CIRCI group (1341.6 ± 1112.5 vs. 976.0 ± 798.7 nmol/L, p = 0.24). ROC analysis demonstrated poor diagnostic performance (AUC 0.61, 95% CI: 0.44-0.78). International guideline cutoff of <276 nmol/L showed 0% sensitivity in identifying CIRCI. Multiple thresholds yielded negative Youden indices, indicating performance of cortisol levels being worse than a random chance. DCA demonstrated zero net benefit for cortisol-guided therapy across all threshold probabilities when compared to clincial practice strategies. Only clinical factors predicted corticosteroid initiation: high vasopressor requirements (OR 3.2, 95% CI: 1.1-9.4, p = 0.03) and persistent shock >48 h (OR 2.8, 95% CI: 1.0-7.9, p = 0.05). Cortisol level had no predictive value (OR 1.0, 95% CI: 0.9-1.0, p = 0.89). Conclusions: In this cohort, baseline total cortisol demonstrated poor diagnostic accuracy and lacked clinical utility for guiding corticosteroid therapy in patients with sepsis. Our findings reinforce the importance of clinical judgement over biochemical testing in identifying patients with septic shock requiring corticosteroid therapy, in line with the recent international guidelines.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Pericarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Cushing Syndrome I: Introduction
Cushing Syndrome II: Pathophysiology

